Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for sedation in autistic children undergoing colonic TET
NCT05960942Completed
- Sponsor
- The Second Affiliated Hospital of Nanjing Medical University
- Start
- Aug 2023
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of esketamine in Autism Spectrum Disorder (ASD) (2 arms), sponsored by The Second Affiliated Hospital of Nanjing Medical University. Primary endpoints: movement score during the procedure and first movement time. Started Aug 2023; status: completed.
02
Drugs
esketamine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT05960942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05960942.